Impact of early dose intensity on cytogenetic and molecular responses in chronicphase CMLpatients receiving 600 mg/day of imatinib as initial therapy

T.P. Hughes; S. Branford; D.L. White; J. Reynolds; R. Koelmeyer; J.F. Seymour; K. Taylor; C. Arthur; A. Schwarer; J. Morton; J. Cooney; M.F. Leahy; P. Rowlings; J. Catalano; M. Hertzberg; R. Filshie; A.K. Mills; K. Fay; S. Durrant; H. Januszewicz; David Joske; C. Underhill; S. Dunkley; K. Lynch; A. Grigg

doi:10.1182/blood-2008-06-161737

Impact of early dose intensity on cytogenetic and molecular responses in chronicphase CMLpatients receiving 600 mg/day of imatinib as initial therapy

T.P. Hughes, S. Branford, D.L. White, J. Reynolds, R. Koelmeyer, J.F. Seymour, K. Taylor, C. Arthur, A. Schwarer, J. Morton, J. Cooney, M.F. Leahy, P. Rowlings, J. Catalano, M. Hertzberg, R. Filshie, A.K. Mills, K. Fay, S. Durrant, H. JanuszewiczDavid Joske, C. Underhill, S. Dunkley, K. Lynch, A. Grigg

Research output: Contribution to journal › Article › peer-review

146 Citations (Scopus)

Original language	English
Pages (from-to)	3965-3973
Journal	Blood
Volume	112
Issue number	10
DOIs	https://doi.org/10.1182/blood-2008-06-161737
Publication status	Published - 2008

Access to Document

10.1182/blood-2008-06-161737

Cite this

Hughes, T. P., Branford, S., White, D. L., Reynolds, J., Koelmeyer, R., Seymour, J. F., Taylor, K., Arthur, C., Schwarer, A., Morton, J., Cooney, J., Leahy, M. F., Rowlings, P., Catalano, J., Hertzberg, M., Filshie, R., Mills, A. K., Fay, K., Durrant, S., ... Grigg, A. (2008). Impact of early dose intensity on cytogenetic and molecular responses in chronicphase CMLpatients receiving 600 mg/day of imatinib as initial therapy. Blood, 112(10), 3965-3973. https://doi.org/10.1182/blood-2008-06-161737

@article{dfc63479eac0470d940a88ef06a946e8,

title = "Impact of early dose intensity on cytogenetic and molecular responses in chronicphase CMLpatients receiving 600 mg/day of imatinib as initial therapy",

author = "T.P. Hughes and S. Branford and D.L. White and J. Reynolds and R. Koelmeyer and J.F. Seymour and K. Taylor and C. Arthur and A. Schwarer and J. Morton and J. Cooney and M.F. Leahy and P. Rowlings and J. Catalano and M. Hertzberg and R. Filshie and A.K. Mills and K. Fay and S. Durrant and H. Januszewicz and David Joske and C. Underhill and S. Dunkley and K. Lynch and A. Grigg",

year = "2008",

doi = "10.1182/blood-2008-06-161737",

language = "English",

volume = "112",

pages = "3965--3973",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "10",

}

Hughes, TP, Branford, S, White, DL, Reynolds, J, Koelmeyer, R, Seymour, JF, Taylor, K, Arthur, C, Schwarer, A, Morton, J, Cooney, J, Leahy, MF, Rowlings, P, Catalano, J, Hertzberg, M, Filshie, R, Mills, AK, Fay, K, Durrant, S, Januszewicz, H, Joske, D, Underhill, C, Dunkley, S, Lynch, K & Grigg, A 2008, 'Impact of early dose intensity on cytogenetic and molecular responses in chronicphase CMLpatients receiving 600 mg/day of imatinib as initial therapy', Blood, vol. 112, no. 10, pp. 3965-3973. https://doi.org/10.1182/blood-2008-06-161737

TY - JOUR

T1 - Impact of early dose intensity on cytogenetic and molecular responses in chronicphase CMLpatients receiving 600 mg/day of imatinib as initial therapy

AU - Hughes, T.P.

AU - Branford, S.

AU - White, D.L.

AU - Reynolds, J.

AU - Koelmeyer, R.

AU - Seymour, J.F.

AU - Taylor, K.

AU - Arthur, C.

AU - Schwarer, A.

AU - Morton, J.

AU - Cooney, J.

AU - Leahy, M.F.

AU - Rowlings, P.

AU - Catalano, J.

AU - Hertzberg, M.

AU - Filshie, R.

AU - Mills, A.K.

AU - Fay, K.

AU - Durrant, S.

AU - Januszewicz, H.

AU - Joske, David

AU - Underhill, C.

AU - Dunkley, S.

AU - Lynch, K.

AU - Grigg, A.

PY - 2008

Y1 - 2008

U2 - 10.1182/blood-2008-06-161737

DO - 10.1182/blood-2008-06-161737

M3 - Article

C2 - 18768781

SN - 0006-4971

VL - 112

SP - 3965

EP - 3973

JO - Blood

JF - Blood

IS - 10

ER -